Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism

被引:45
作者
Kato, K [1 ]
Sato, H [1 ]
Takebe, Y [1 ]
机构
[1] Natl Inst Infect Dis, Ctr AIDS Res, Lab Mol Virol & Epidemiol, Shinjuku Ku, Tokyo 1628640, Japan
关键词
D O I
10.1128/JVI.73.7.5520-5526.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To assess the role of naturally occurring basic amino acid substitutions in the V3 loop of human immunodeficiency virus type 1 (HN-I) subtype E on viral coreceptor usage and cell tropism, we have constructed a panel of chimeric viruses with mutant V3 loops of HIV-1 subtype E in the genetic background of HIV-1(LAI). The arginine substitutions naturally occurring at positions 8, 11, and 18 of the V3 loop in an HIV-1 subtype E X4 strain were systematically introduced into that of an R5 strain to generate a series of V3 loop mutant chimera. These chimeric viruses were employed in virus infectivity assays using HOS-CD4 cells expressing either CCR5 or CXCR4, peripheral blood mononuclear cells, T-cell lines, or macrophages. The arginine substitution at position 11 of the V3 loop uniformly caused the loss of infectivity in HOS-CD4-CCR5 cells, indicating that position 11 is critical for utilization of CCR5. CXCR4 usage was conferred by a minimum of two arginine substitutions, regardless of combination, whereas arginine substitutions at position 8 and 11 were required for T-cell line tropism. Nonetheless, macrophage tropism was not conferred by the V3 loop of subtype E R5 strain per se. We found that the specific combinations of amino acid changes in HIV-1 subtype E env V3 loop are critical for determining viral coreceptor usage and cell tropism, However, the ability to infect HOS-CD4 cells through either CXCR5 or CCR5 is not necessarily correlated with T-cell or macrophage tropism, suggesting that cellular tropism is not dictated solely by viral coreceptor utilization.
引用
收藏
页码:5520 / 5526
页数:7
相关论文
共 42 条
  • [1] AN N-GLYCAN WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 V3 LOOP AFFECTS VIRUS NEUTRALIZATION
    BACK, NKT
    SMIT, L
    DEJONG, JJ
    KEULEN, W
    SCHUTTEN, M
    GOUDSMIT, J
    TERSMETTE, M
    [J]. VIROLOGY, 1994, 199 (02) : 431 - 438
  • [2] MACROPHAGE-TROPIC HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATES FROM DIFFERENT PATIENTS EXHIBIT UNUSUAL V3 ENVELOPE SEQUENCE HOMOGENEITY IN COMPARISON WITH T-CELL-TROPIC ISOLATES - DEFINITION OF CRITICAL AMINO-ACIDS INVOLVED IN CELL TROPISM
    CHESEBRO, B
    WEHRLY, K
    NISHIO, J
    PERRYMAN, S
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (11) : 6547 - 6554
  • [3] Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4
    Cho, MW
    Lee, MK
    Carney, MC
    Berson, JF
    Doms, RW
    Martin, MA
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (03) : 2509 - 2515
  • [4] The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
    Choe, H
    Farzan, M
    Sun, Y
    Sullivan, N
    Rollins, B
    Ponath, PD
    Wu, LJ
    Mackay, CR
    LaRosa, G
    Newman, W
    Gerard, N
    Gerard, C
    Sodroski, J
    [J]. CELL, 1996, 85 (07) : 1135 - 1148
  • [5] The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection
    Cocchi, F
    DeVico, AL
    GarzinoDemo, A
    Cara, A
    Gallo, RC
    Lusso, P
    [J]. NATURE MEDICINE, 1996, 2 (11) : 1244 - 1247
  • [6] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WITH INCREASED REPLICATIVE CAPACITY DEVELOP DURING THE ASYMPTOMATIC STAGE BEFORE DISEASE PROGRESSION
    CONNOR, RI
    HO, DD
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (07) : 4400 - 4408
  • [7] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CLONES CHIMERIC FOR THE ENVELOPE V3 DOMAIN DIFFER IN SYNCYTIUM FORMATION AND REPLICATION CAPACITY
    DEJONG, JJ
    GOUDSMIT, J
    KEULEN, W
    KLAVER, B
    KRONE, W
    TERSMETTE, M
    DERONDE, A
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (02) : 757 - 765
  • [8] MINIMAL REQUIREMENTS FOR THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 V3 DOMAIN TO SUPPORT THE SYNCYTIUM-INDUCING PHENOTYPE - ANALYSIS BY SINGLE AMINO-ACID SUBSTITUTION
    DEJONG, JJ
    DERONDE, A
    KEULEN, W
    TERSMETTE, M
    GOUDSMIT, J
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (11) : 6777 - 6780
  • [9] Identification of a major co-receptor for primary isolates of HIV-1
    Deng, HK
    Liu, R
    Ellmeier, W
    Choe, S
    Unutmaz, D
    Burkhart, M
    DiMarzio, P
    Marmon, S
    Sutton, RE
    Hill, CM
    Davis, CB
    Peiper, SC
    Schall, TJ
    Littman, DR
    Landau, NR
    [J]. NATURE, 1996, 381 (6584) : 661 - 666
  • [10] PHENOTYPE-ASSOCIATED SEQUENCE VARIATION IN THE 3RD VARIABLE DOMAIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 MOLECULE
    FOUCHIER, RAM
    GROENINK, M
    KOOTSTRA, NA
    TERSMETTE, M
    HUISMAN, HG
    MIEDEMA, F
    SCHUITEMAKER, H
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (05) : 3183 - 3187